Immune Modulation and Efficacy of Tixagevimab/Cilgavimab Pre-Exposure Prophylaxis in Lung Transplant Recipients During the Omicron Wave.

Int J Mol Sci · 2025 · PMC12027920 · PMID 40332340

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

a significant trendno p-value reported

Conversely, we detected a significant trend in patients who did not experience COVID-19 after PrEP ( Figure 1 C).

also in 9,774 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.